Support and Brace Support and Brace

Calendar

March 2019
M T W T F S S
« Jan    
 123
45678910
11121314151617
18192021222324
25262728293031

Posts Tagged ‘tanezumab’

cancel study

Pfizer suspended clinical trial of their new infusion therapy drug, Tanezumab. ¬†Apparently some patient’s condition became worse.

The worldwide program was cancelled after the FDA reported the osteoarthritis in some patients became so bad so quickly that they needed to have their knees replaced!

Pfizer is no longer accepting new patients into their trials of Tanezumab and has suspended dosing of existing patients in the OA program.

The FDA is demanding that Pfizer present information on the problems associated with Tanezumab reported in their other clinical studies.